User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 7 results.
    • Journal article
    A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
    Harrison, Stephen A. Bedossa, Pierre Guy, Cynthia D. Schattenberg, Jörn M. Loomba, Rohit Taub, Rebecca Labriola, Dominic Moussa, Sam E. Neff, Guy W. Rinella, Mary E. Anstee, Quentin M. Abdelmalek, Manal F. Younossi, Zobair Baum, Seth J. Francque, Sven Charlton, Michael R. Newsome, Philip N. Lanthier, Nicolas[UCL] Schiefke, Ingolf Mangia, Alessandra Pericàs, Juan M. Patil, Rashmee Sanyal, Arun J. Noureddin, Mazen Bansal, Meena B. Alkhouri, Naim Castera, Laurent Rudraraju, Madhavi Ratziu, Vlad (2024) New England Journal of Medicine — Vol. 390, no.6, p. 497-509 (2024)
    • Speech
    Selection based on SAF activity score, not NASH CRN NAFLD activity score, leads to selection of a patient cohort with more severe NASH with more advanced fibrosis: experience from the NATIVE phase 2b study of the PanPPAR agonist lanifibranor
    Francque, Sven Bedossa, Pierre Ratziu, Vlad Anstee, Quentin Bugianesi, Elisabetta Sanyal, Arun Loomba, Rohit Harrison, Stephen A. Balabanska, Rozalina Ivanova Mateva, Lyudmila Lanthier, Nicolas[UCL] (2020) The Liver Meeting Digital Experience —
    • Journal article
    Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy.
    Poynard, Thierry Colombo, Massimo Bruix, Jordi Schiff, Eugene Terg, Ruben Flamm, Steven Moreno-Otero, Ricardo Carrilho, Flair Schmidt, Warren Berg, Thomas McGarrity, Thomas Heathcote, E Jenny Gonçales, Fernando Diago, Moises Craxi, Antonio Silva, Marcelo Bedossa, Pierre Mukhopadhyay, Pabak Griffel, Louis Burroughs, Margaret Brass, Clifford Albrecht, Janice Epic Study Group Horsmans, Yves[UCL] (2009) Gastroenterology — Vol. 136, no.5, p. 1618-1628.e2 (2009)
    • Journal article
    N-butyl-2-cyanoacrylate in gastric varices: A cause for recurrent repsis
    Ausloos, Floriane[UCL] Hillaire, Sophie Bedossa, Pierre Bert, Fréderic Moreno, Christophe Geubel, André[UCL] Plessier, Aurélie Valla, Dominique (2013) The American journal of gastroenterology — Vol. 108, no. 12, p. 1937-1938 (2013)
    • Speech
    The PanPPAR agonist lanifibranor induces both resolution of NASH and regression of fibrosis after 24 weeks of treatment in non-cirrhotic NASH: results of the NATIVE Phase 2b trial
    Francque, Sven Bedossa, Pierre Ratziu, Vlad Anstee, Quentin Bugianesi, Elisabetta Sanyal, Arun Loomba, Rohit Harrison, Stephen A Balabanska, Rozalina Ivanova Mateva, Lyudmila Lanthier, Nicolas[UCL] (2020) The Liver Meeting Digital Experience —
    • Journal article
    A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
    Francque, Sven M. Bedossa, Pierre Ratziu, Vlad Anstee, Quentin M. Bugianesi, Elisabetta Sanyal, Arun J. Loomba, Rohit Harrison, Stephen A. Balabanska, Rozalina Mateva, Lyudmila Lanthier, Nicolas[UCL] Alkhouri, Naim Moreno, Christophe Schattenberg, Jörn M. Stefanova-Petrova, Diana Vonghia, Luisa Rouzier, Régine Guillaume, Maeva Hodge, Alexander Romero-Gómez, Manuel Huot-Marchand, Philippe Baudin, Martine Richard, Marie-Paule Abitbol, Jean-Louis Broqua, Pierre Junien, Jean-Louis Abdelmalek, Manal F. (2021) New England Journal of Medicine — Vol. 385, no. 17, p. 1547-1558 (2021)
    • Journal article
    Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I
    Calderaro, Julien Labrune, Philippe Morcrette, Guillaume Rebouissou, Sandra Franco, Dominique Prévot, Sophie Quaglia, Alberto Bedossa, Pierre Libbrecht, Louis[UCL] Terracciano, Luigi Smit, G Peter A Bioulac-Sage, Paulette Zucman-Rossi, Jessica (2013) Journal of Hepatology — Vol. 58, no.2, p. 350-357 (2013)